NO172133C - Fremgangsmaate for fremstilling av nye humane vevstypeplasminogenaktivatorpolypeptider - Google Patents

Fremgangsmaate for fremstilling av nye humane vevstypeplasminogenaktivatorpolypeptider

Info

Publication number
NO172133C
NO172133C NO871086A NO871086A NO172133C NO 172133 C NO172133 C NO 172133C NO 871086 A NO871086 A NO 871086A NO 871086 A NO871086 A NO 871086A NO 172133 C NO172133 C NO 172133C
Authority
NO
Norway
Prior art keywords
preparation
human tissue
procedure
plasminogen activator
tissue plasminogen
Prior art date
Application number
NO871086A
Other languages
English (en)
Norwegian (no)
Other versions
NO871086D0 (no
NO172133B (no
NO871086L (no
Inventor
Adair John Hotchkiss
Connor John Vincent O
Michael Walter Spellman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO871086D0 publication Critical patent/NO871086D0/no
Publication of NO871086L publication Critical patent/NO871086L/no
Publication of NO172133B publication Critical patent/NO172133B/no
Publication of NO172133C publication Critical patent/NO172133C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO871086A 1986-03-18 1987-03-17 Fremgangsmaate for fremstilling av nye humane vevstypeplasminogenaktivatorpolypeptider NO172133C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84107586A 1986-03-18 1986-03-18
US2189387A 1987-03-04 1987-03-04

Publications (4)

Publication Number Publication Date
NO871086D0 NO871086D0 (no) 1987-03-17
NO871086L NO871086L (no) 1987-09-21
NO172133B NO172133B (no) 1993-03-01
NO172133C true NO172133C (no) 1993-06-09

Family

ID=26695219

Family Applications (1)

Application Number Title Priority Date Filing Date
NO871086A NO172133C (no) 1986-03-18 1987-03-17 Fremgangsmaate for fremstilling av nye humane vevstypeplasminogenaktivatorpolypeptider

Country Status (19)

Country Link
EP (1) EP0238304B1 (de)
JP (1) JP2972812B2 (de)
AT (1) ATE139569T1 (de)
AU (1) AU602510B2 (de)
CA (1) CA1341597C (de)
DD (1) DD258999A5 (de)
DE (2) DE3708681C2 (de)
DK (1) DK175490B1 (de)
ES (1) ES2088860T3 (de)
FI (1) FI100802B (de)
FR (1) FR2597883B1 (de)
GB (1) GB2189249B (de)
GR (1) GR3020850T3 (de)
HU (1) HU202276B (de)
IE (1) IE81073B1 (de)
IL (1) IL81937A (de)
NO (1) NO172133C (de)
NZ (1) NZ219654A (de)
PT (1) PT84493B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178105B1 (de) * 1984-10-01 1997-04-02 Genzyme Corporation Rekombinante DNS-Verfahren und dadurch hergestellte Produkte
US5108909A (en) * 1985-03-22 1992-04-28 Chiron Corporation Expression of TPA in mammalian cells
ES2031826T3 (es) * 1985-12-23 1993-01-01 Chiron Corporation Procedimiento para producir nuevos peptidos activadores del plasminogeno.
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins
US4851517A (en) * 1986-02-26 1989-07-25 Monsanto Company Tissue plasminogen activator oligosaccharide from normal human colon cells
US4927630A (en) * 1986-02-26 1990-05-22 Monsanto Company Tissue plasminogen activator from normal human colon cells
JPH084501B2 (ja) * 1987-03-20 1996-01-24 エーザイ株式会社 糖鎖に関する変異ｔＰＡ
EP0293934B1 (de) * 1987-06-04 1994-08-31 Zymogenetics, Inc. Mutierter t-PA mit Kringle-Ersatz
AU615919B2 (en) * 1987-07-01 1991-10-17 Beecham Group Plc Hybrid plasminogen activators
US5244676A (en) * 1987-10-09 1993-09-14 Monsanto Company Modified tissue plasminogen activator with modified glycosylation site
IL88247A0 (en) * 1987-11-06 1989-06-30 Genentech Inc Novel human tissue-type plasminogen activator variant
US5346824A (en) * 1988-05-20 1994-09-13 Genentech, Inc. DNA encoding variants of tissue plasminogen activators and expression vectors and hosts thereof
IL90146A (en) * 1988-05-20 1994-10-07 Genentech Inc Glycosylation derivatives of tissue plasminogen activator
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
DE3841296A1 (de) * 1988-12-08 1990-06-13 Bosch Gmbh Robert Antiblockierregelsystem
US5070021A (en) * 1989-01-10 1991-12-03 Monsanto Company Method of modifying oligosaccharide structure of tissue plasminogen activator
US5242688A (en) * 1990-12-24 1993-09-07 Eli Lilly And Company Method of treating thromboembolic disorders by administration of diglycosylated t-pa variants
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
ATE155816T1 (de) 1992-06-03 1997-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
US6506598B1 (en) 1999-04-26 2003-01-14 Genentech, Inc. Cell culture process
US7084118B2 (en) 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU200615B (en) * 1982-05-05 1990-07-28 Genentech Inc Methods of preparing tissue plasiminogen activator derivative composition
EP0125254A1 (de) * 1982-10-28 1984-11-21 Beecham Group Plc Enzymderivate und deren verwendung bei der behandlung von trombosen
EP0125269A1 (de) * 1982-11-11 1984-11-21 Beecham Group Plc Pharmazeutisch aktive verbindungen
EP0178105B1 (de) * 1984-10-01 1997-04-02 Genzyme Corporation Rekombinante DNS-Verfahren und dadurch hergestellte Produkte
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
JPS61247384A (ja) * 1984-10-18 1986-11-04 チモ−ジエネテイツクス　インコ−ポレ−テツド 酵母中でプラスミノ−ゲン活性化因子を発現する方法
GR861037B (en) * 1985-04-22 1986-07-16 Genentech Inc Novel human tissue plasminogen activator mutants
JPH0811066B2 (ja) * 1985-09-30 1996-02-07 インテグレーテッド・ジエネティックス・インコーポレーテッド 組換えｄｎａが生産するヒト子宮プラスミノ−ゲンアクチベ−タ−
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
ES2031826T3 (es) * 1985-12-23 1993-01-01 Chiron Corporation Procedimiento para producir nuevos peptidos activadores del plasminogeno.
WO1987004722A1 (en) * 1986-01-31 1987-08-13 Genetics Institute, Inc. Novel thrombolytic proteins

Also Published As

Publication number Publication date
PT84493A (en) 1987-04-01
AU602510B2 (en) 1990-10-18
DD258999A5 (de) 1988-08-10
GB2189249B (en) 1990-10-31
JP2972812B2 (ja) 1999-11-08
FI871175L (fi) 1987-09-19
NO871086D0 (no) 1987-03-17
GR3020850T3 (en) 1996-11-30
IL81937A0 (en) 1987-10-20
NO172133B (no) 1993-03-01
NO871086L (no) 1987-09-21
GB2189249A (en) 1987-10-21
JPS62282582A (ja) 1987-12-08
DK135887D0 (da) 1987-03-17
ATE139569T1 (de) 1996-07-15
EP0238304A2 (de) 1987-09-23
IE870691L (en) 1987-09-18
DE3751842D1 (de) 1996-07-25
PT84493B (pt) 1989-11-10
AU7008887A (en) 1987-09-24
HUT43108A (en) 1987-09-28
IL81937A (en) 1994-07-31
FR2597883A1 (fr) 1987-10-30
EP0238304B1 (de) 1996-06-19
CA1341597C (en) 2009-06-23
ES2088860T3 (es) 1996-10-01
FI100802B (fi) 1998-02-27
IE81073B1 (en) 2000-01-12
NZ219654A (en) 1990-08-28
FR2597883B1 (fr) 1990-04-20
DK175490B1 (da) 2004-11-08
HU202276B (en) 1991-02-28
EP0238304A3 (en) 1988-07-06
DE3708681A1 (de) 1987-10-01
DK135887A (da) 1987-09-19
DE3751842T2 (de) 1996-11-28
GB8706249D0 (en) 1987-04-23
FI871175A0 (fi) 1987-03-18
DE3708681C2 (de) 1995-08-17

Similar Documents

Publication Publication Date Title
NO172133C (no) Fremgangsmaate for fremstilling av nye humane vevstypeplasminogenaktivatorpolypeptider
DK172089D0 (da) 1,3-dioxolanderivater samt fremgangsmaade til fremstilling deraf
IL80659A0 (en) Modified tissue plasminogen activators,their preparation and pharmaceutical compositions containing them
EP0272928A3 (en) Compositions and methods for the synthesis and assay of enkephalinase
FI902239A0 (fi) Nya maennskavaevnadsliknande plasminogen aktivator variant.
DE59008693D1 (de) Gewebs-Plasminogen-Aktivator-Derivat.
DK96888A (da) Rekombinant humant vaevsplasminogen aktivatormateriale